$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

$esta Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-K Financial Statement

#000168875720000015 Filed on March 16, 2020

Income Statement

Concept	2020 Q1	2018 Q4	2018
Revenue	$24.48M	$16.40M	$61.21M
YoY Change	17.82%	38.87%	76.49%
Cost Of Revenue	$9.003M	$6.520M	$25.09M
YoY Change	-5.49%	24.19%	47.77%
Gross Profit	$15.48M	$9.870M	$36.12M
YoY Change	37.56%	50.46%	104.03%
Gross Profit Margin	63.22%	60.18%	59.01%
Selling, General & Admin	$18.98M	$14.83M	$47.30M
YoY Change	18.24%	70.26%	53.45%
% of Gross Profit	122.65%	150.25%	130.95%
Research & Development	$4.199M	$3.660M	$12.69M
YoY Change	17.16%	50.0%	84.83%
% of Gross Profit	27.13%	37.08%	35.13%
Depreciation & Amortization	$20.00K	$770.0K	$2.810M
YoY Change	-4.76%	30.51%	44.85%
% of Gross Profit	0.13%	7.8%	7.78%
Operating Expenses	$23.18M	$18.50M	$59.98M
YoY Change	18.04%	65.92%	59.17%
Operating Profit	-$7.705M	-$8.630M	-$23.86M
YoY Change	-8.14%	88.02%	19.42%
Interest Expense	$2.146M	-$2.310M	$8.814M
YoY Change	-4.28%	10.0%	-15.41%
% of Operating Profit
Other Income/Expense, Net	-$6.190M	$570.0K	-$2.388M
YoY Change	1936.18%	-254.05%	504.56%
Pretax Income	-$17.52M	-$10.36M	-$20.88M
YoY Change	63.22%	46.74%	-39.98%
Income Tax	$231.0K	$150.0K	$215.0K
% Of Pretax Income
Net Earnings	-$17.75M	-$10.51M	-$21.10M
YoY Change	64.7%	47.41%	-39.54%
Net Earnings / Revenue	-72.52%	-64.09%	-34.47%
Basic Earnings Per Share
Diluted Earnings Per Share	-$790.3K	-$515.4K	-$1.035M
COMMON SHARES
Basic Shares Outstanding	23.33M shares	20.54M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q1	2018 Q4	2018
SHORT-TERM ASSETS
Cash & Short-Term Investments	$93.60M	$52.60M	$52.60M
YoY Change	117.17%	382.57%	382.57%
Cash & Equivalents	$93.60M	$52.64M
Short-Term Investments
Other Short-Term Assets	$7.200M	$4.300M	$4.300M
YoY Change	53.19%	95.45%	95.45%
Inventory	$25.51M	$24.85M	$24.80M
Prepaid Expenses
Receivables	$21.62M	$17.65M	$17.60M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$147.9M	$99.44M	$99.40M
YoY Change	61.25%	152.49%	152.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.24M	$12.91M	$12.90M
YoY Change	22.97%	-4.35%	-4.44%
Goodwill	$465.0K	$465.0K
YoY Change	0.0%	0.0%
Intangibles	$3.465M	$3.445M
YoY Change	6.68%	1.29%
Long-Term Investments
YoY Change
Other Assets	$362.0K	$315.0K	$300.0K
YoY Change	11.38%	15.81%	0.0%
Total Long-Term Assets	$20.53M	$17.14M	$17.20M
YoY Change	19.07%	-3.25%	-2.82%
TOTAL ASSETS
Total Short-Term Assets	$147.9M	$99.44M	$99.40M
Total Long-Term Assets	$20.53M	$17.14M	$17.20M
Total Assets	$168.4M	$116.6M	$116.6M
YoY Change	54.58%	104.17%	104.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.881M	$6.239M	$6.200M
YoY Change	76.98%	-31.67%	-31.87%
Accrued Expenses	$10.56M	$6.125M	$5.800M
YoY Change	54.18%	163.33%	114.81%
Deferred Revenue	$669.0K	$908.0K
YoY Change	-1.76%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due	$200.0K	$300.0K	$300.0K
YoY Change		0.0%	0.0%
Total Short-Term Liabilities	$22.46M	$16.45M	$16.40M
YoY Change	35.64%	-71.36%	-71.43%
LONG-TERM LIABILITIES
Long-Term Debt	$48.50M	$22.30M	$22.30M
YoY Change	109.05%
Other Long-Term Liabilities	$2.126M	$3.551M	$8.300M
YoY Change	-37.06%	-24.01%	76.6%
Total Long-Term Liabilities	$2.126M	$3.551M	$30.60M
YoY Change	-37.06%	-24.01%	551.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.46M	$16.45M	$16.40M
Total Long-Term Liabilities	$2.126M	$3.551M	$30.60M
Total Liabilities	$78.12M	$47.09M	$47.10M
YoY Change	62.99%	-24.18%	-24.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$144.9M	-$88.98M
YoY Change	45.24%	31.08%
Common Stock	$211.7M	$145.7M
YoY Change	44.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.854M	$2.854M
YoY Change	0.0%	-55.85%
Treasury Stock Shares	408.1K shares	408.1K shares
Shareholders Equity	$90.31M	$69.49M	$69.50M
YoY Change
Total Liabilities & Shareholders Equity	$168.4M	$116.6M	$116.6M
YoY Change	54.58%	104.17%	104.2%

Cashflow Statement

Concept	2020 Q1	2018 Q4	2018
OPERATING ACTIVITIES
Net Income	-$17.75M	-$10.51M	-$21.10M
YoY Change	64.7%	47.41%	-39.54%
Depreciation, Depletion And Amortization	$20.00K	$770.0K	$2.810M
YoY Change	-4.76%	30.51%	44.85%
Cash From Operating Activities	-$6.802M	-$8.480M	-$33.89M
YoY Change	-14.95%	4.18%	5.99%
INVESTING ACTIVITIES
Capital Expenditures	$687.0K	-$470.0K	$1.731M
YoY Change	0.29%	-204.44%	92.12%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$3.960M	-$3.960M
YoY Change	-100.0%		-4060.0%
Cash From Investing Activities	-$949.0K	-$4.430M	-$5.731M
YoY Change	-34.78%	-1106.82%	578.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$63.86M		$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$63.93M	-60.00K	$81.53M
YoY Change	-399637.5%	-100.44%	89.63%
NET CHANGE
Cash From Operating Activities	-$6.802M	-8.480M	-$33.89M
Cash From Investing Activities	-$949.0K	-4.430M	-$5.731M
Cash From Financing Activities	$63.93M	-60.00K	$81.53M
Net Change In Cash	$55.94M	-12.97M	$41.78M
YoY Change	-688.6%	-317.62%	310.44%
FREE CASH FLOW
Cash From Operating Activities	-$6.802M	-$8.480M	-$33.89M
Capital Expenditures	$687.0K	-$470.0K	$1.731M
Free Cash Flow	-$7.489M	-$8.010M	-$35.62M
YoY Change	-13.75%	-6.75%	8.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7320000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	495000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6125000	USD
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001688757
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23326060	shares
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019Q2	dei	Entity Public Float EntityPublicFloat	299678686	USD
CY2019	dei	Entity Registrant Name EntityRegistrantName	Establishment Labs Holdings Inc.
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018Q4	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	1763000	USD
CY2019Q4	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	4212000	USD
CY2018Q4	esta	Advisory Board And Board Of Director Liabilities Current AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent	165000	USD
CY2019Q4	esta	Advisory Board And Board Of Director Liabilities Current AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent	124000	USD
CY2018Q4	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	0	USD
CY2019Q4	esta	Cash Payable For Asset Acquisition Current CashPayableForAssetAcquisitionCurrent	492000	USD
CY2018Q4	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	883000	USD
CY2019Q4	esta	Cash Payable For Asset Acquisition Noncurrent CashPayableForAssetAcquisitionNoncurrent	781000	USD
CY2018Q4	esta	Class Of Warrant Or Right Outstanding Current ClassOfWarrantOrRightOutstandingCurrent	2261000	USD
CY2019Q4	esta	Class Of Warrant Or Right Outstanding Current ClassOfWarrantOrRightOutstandingCurrent	0	USD
CY2018	esta	Deferred Offering Expense DeferredOfferingExpense	-1468000	USD
CY2019	esta	Deferred Offering Expense DeferredOfferingExpense	0	USD
CY2018	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	2200000	USD
CY2019	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	2700000	USD
CY2018	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	2810000	USD
CY2019	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	3288000	USD
CY2018	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Amount EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentAmount	553000	USD
CY2019	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Amount EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentAmount	391000	USD
CY2018	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Percent EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentPercent	-0.03
CY2019	esta	Effective Income Tax Rate Reconciliation Returnto Provision Adjustment Percent EffectiveIncomeTaxRateReconciliationReturntoProvisionAdjustmentPercent	-0.01
CY2019	esta	Employee And Non Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized Periodfor Recognition EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition	P2Y4M24D
CY2018	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	1276000	USD
CY2019	esta	Noncash Consideration Payable Relatedto Asset Acquisition NoncashConsiderationPayableRelatedtoAssetAcquisition	1271000	USD
CY2018	esta	Noncash Deferred Offering Expense NoncashDeferredOfferingExpense	120000	USD
CY2019	esta	Noncash Deferred Offering Expense NoncashDeferredOfferingExpense	337000	USD
CY2018	esta	Noncash Issuance Of Common Shares In Partial Settlement Of Contingent Consideration NoncashIssuanceOfCommonSharesInPartialSettlementOfContingentConsideration	863000	USD
CY2019	esta	Noncash Issuance Of Common Shares In Partial Settlement Of Contingent Consideration NoncashIssuanceOfCommonSharesInPartialSettlementOfContingentConsideration	630000	USD
CY2018	esta	Noncashor Part Noncash Transfer From Restricted Cash To Prepaid Expenses And Other Currents Assets NoncashorPartNoncashTransferFromRestrictedCashToPrepaidExpensesAndOtherCurrentsAssets	75000	USD
CY2019	esta	Noncashor Part Noncash Transfer From Restricted Cash To Prepaid Expenses And Other Currents Assets NoncashorPartNoncashTransferFromRestrictedCashToPrepaidExpensesAndOtherCurrentsAssets	0	USD
CY2019	esta	Number Of Employees Represented By A Labor Union NumberOfEmployeesRepresentedByALaborUnion	45	employee
CY2019Q4	esta	Number Of Manufacturing Facilities NumberOfManufacturingFacilities	2	facility
CY2018	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	3959000	USD
CY2019	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	767000	USD
CY2019	esta	Revenue From Contract With Customer Product Return Period RevenueFromContractWithCustomerProductReturnPeriod	P15D
CY2019	esta	Revenue From Contract With Customer Product Shelf Life RevenueFromContractWithCustomerProductShelfLife	P5Y
CY2018	esta	Sharebased Compensation And Issuance Of Stock Or Warrants For Services And Claims SharebasedCompensationAndIssuanceOfStockOrWarrantsForServicesAndClaims	7320000	USD
CY2019	esta	Sharebased Compensation And Issuance Of Stock Or Warrants For Services And Claims SharebasedCompensationAndIssuanceOfStockOrWarrantsForServicesAndClaims	6526000	USD
CY2019	esta	Stock Issued During Period Shares Warrant Exercises StockIssuedDuringPeriodSharesWarrantExercises	92231	shares
CY2018	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	121000	USD
CY2019	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	56000	USD
CY2018	esta	Warrant Extinguishmentof Warrants Related Party WarrantExtinguishmentofWarrantsRelatedParty	862000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6239000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10366000	USD
CY2018Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	0	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17648000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22767000	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1295000	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2080000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10677000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15156000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3317000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	122000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	500000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1300000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1996000	USD
CY2018Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	487000	USD
CY2019Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	522000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5230000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7522000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	449000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	691000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21214000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	224000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7320000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6526000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	926000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1026000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2428000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1905312	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1823198	shares
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q4	us-gaap	Assets Assets	116573000	USD
CY2019Q4	us-gaap	Assets Assets	116531000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	99435000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	95839000	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1727000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-276000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	914000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	922000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	914000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	717000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	465000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	336000	USD
CY2019Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	258000	USD
CY2018	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	94000	USD
CY2019	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	69000	USD
CY2019Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	207000	USD
CY2018Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1400000	USD
CY2019Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1500000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	503000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	286000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	39000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2300000	shares
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10864000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52639000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	178000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	38000	USD
CY2019Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	465000	USD
CY2018Q4	us-gaap	Cash Cash	52639000	USD
CY2019Q4	us-gaap	Cash Cash	37655000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37655000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	41775000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14984000	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2019Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3020460	shares
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3571406	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20672025	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21057040	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20263955	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20648970	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	145709000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	147688000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20725000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37908000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	52000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	36000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	908000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	785000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1186000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1344000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	25090000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	34704000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	105000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	110000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	640000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	215000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	640000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	206000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	62000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	128000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	20000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5738000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7842000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6055000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8261000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	131000	USD
CY2018Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1500000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	73000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	93000	USD
CY2018Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	97000	USD
CY2019Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	85000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	46000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	93000	USD
CY2018Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4768000	USD
CY2019Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3072000	USD
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.22
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.86
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-136000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-24000	USD
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.02
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.12
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.06
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.00
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.00
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.29
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.00
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.00
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.00
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	-0.04
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	-0.04
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6600000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1213000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1923000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	483000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	865000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	235000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-3533000	USD
CY2018	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	15894000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-67000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	465000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	251000	USD
CY2019	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3052000	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-79000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	465000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	821000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3150000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2400000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1200000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2217000	USD
CY2018	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2019	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018	us-gaap	Gross Profit GrossProfit	36118000	USD
CY2019	us-gaap	Gross Profit GrossProfit	54861000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3422000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5022000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20883000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37510000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-24305000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-42532000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	215000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	640000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2439000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2271000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	42000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	6000	USD
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	4335000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	10623000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6265000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11253000	USD
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	98000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	165000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	75000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	56000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Holidays IncomeTaxReconciliationTaxHolidays	912000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Holidays IncomeTaxReconciliationTaxHolidays	1507000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	136000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	649000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3905000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1830000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4667000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5511000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3801000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4644000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6984000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3372000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	45000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5364000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	54000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-28000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	400000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2192000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2538000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2019Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4658000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3445000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3441000	USD
CY2018	us-gaap	Interest Expense InterestExpense	8814000	USD
CY2019	us-gaap	Interest Expense InterestExpense	8696000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	5379000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	5947000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	20252000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	21954000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	24845000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28660000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3349000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5506000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	200000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	300000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1244000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1200000	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	204000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	143000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	16000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	47088000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	76917000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116573000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116531000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16447000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	23242000	USD
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	22322000	USD
CY2019Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	48142000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81527000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22789000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5731000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7766000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33885000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29983000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-21098000	USD
CY2019	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-38150000	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1257000	USD
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2018	us-gaap	Operating Expenses OperatingExpenses	59982000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	85802000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-23864000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-30941000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3588000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	603000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	365000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	374000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	406000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	467000	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1373000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	30000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	672000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	315000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	368000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	373000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	242000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	373000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	242000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4083000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2199000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3551000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2461000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2388000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1205000	USD
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	711000	USD
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1267000	USD
CY2018Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	568000	USD
CY2019Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	336000	USD
CY2017Q3	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	4700000	USD
CY2018	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	USD
CY2019	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	2261000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	224000	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	41000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	711000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1731000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6288000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4303000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6757000	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1126000	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2371000	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	634000	USD
CY2019Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1234000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	24748000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	643000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	712000	USD
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	121000	USD
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	56000	USD
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	148000	USD
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	313000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18143000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23940000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12913000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16418000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-547000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	111000	USD
CY2018	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	311000	USD
CY2019	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	242000	USD
CY2018	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5083000	USD
CY2019	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12687000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14991000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88975000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127125000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61208000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	89565000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	47295000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	70811000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2978000.000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1500000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	22.02
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	77796	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	510000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23778000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	24122000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1486363	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1837576	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.43
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.54
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	14600000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	732411	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	7.72
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.78
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	23.82
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M27D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y22D
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	80991	shares
CY2018	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16102000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	630000	USD
CY2018	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	120000	USD
CY2019	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	337000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6526000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	712000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-5013000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	643000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	69485000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	39614000	USD
CY2018Q4	us-gaap	Supplies Supplies	1832000	USD
CY2019Q4	us-gaap	Supplies Supplies	1885000	USD
CY2019Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	100000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	479000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2018	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	0	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
CY2018	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	15894000	USD
CY2019	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	3052000	USD
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17350705	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20541528	shares
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Other Risks and Uncertainties</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company’s cash is held at two financial institution in the United States. The Company has not experienced any losses on its deposits of cash. All of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">year</font><font style="font-family:Arial;font-size:10pt;">s ended </font><font style="font-family:Arial;font-size:10pt;">December 31, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2018</font><font style="font-family:Arial;font-size:10pt;">, no customers accounted for more than 10% of the Company’s revenue. Substantially all of the Company’s revenues are derived from the sale of Motiva Implants. One customer accounted for </font><font style="font-family:Arial;font-size:10pt;">10.2%</font><font style="font-family:Arial;font-size:10pt;"> of the Company’s accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;color:#000000;">December 31, 2019</font><font style="font-family:Arial;font-size:10pt;">. No customers accounted for more than 10% of the Company’s accounts receivable balance as of December 31, </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">2018</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company relies on NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the </font><font style="font-family:Arial;font-size:10pt;">year</font><font style="font-family:Arial;font-size:10pt;">s ended </font><font style="font-family:Arial;font-size:10pt;">December 31, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2018</font><font style="font-family:Arial;font-size:10pt;">, the Company had purchases of </font><font style="font-family:Arial;font-size:10pt;">$14.2 million</font><font style="font-family:Arial;font-size:10pt;">, or </font><font style="font-family:Arial;font-size:10pt;">58.5%</font><font style="font-family:Arial;font-size:10pt;"> of total purchases, and </font><font style="font-family:Arial;font-size:10pt;">$14.8 million</font><font style="font-family:Arial;font-size:10pt;">, or </font><font style="font-family:Arial;font-size:10pt;">63.4%</font><font style="font-family:Arial;font-size:10pt;"> of total purchases, respectively, from Nusil. As of </font><font style="font-family:Arial;font-size:10pt;">December 31, 2019</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">2018</font><font style="font-family:Arial;font-size:10pt;">, we had an outstanding balance owed to this vendor of </font><font style="font-family:Arial;font-size:10pt;">$2.7 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$0.8 million</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.</font></div></div>
CY2019	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Debt and Embedded Derivatives</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Debt with Conversion and Other Options</font><font style="font-family:Arial;font-size:10pt;"> (see Note 6).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the consolidated statements of operations</font></div></div>
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the </font><font style="font-family:Arial;font-size:10pt;">consolidated</font><font style="font-family:Arial;font-size:10pt;color:#231f20;"> financial statements and accompanying notes. Significant accounting </font><font style="font-family:Arial;font-size:10pt;">estimates and management judgments reflected in the </font><font style="font-family:Arial;font-size:10pt;">consolidated</font><font style="font-family:Arial;font-size:10pt;"> financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets’ useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</font><font style="font-family:Arial;font-size:10pt;color:#231f20;"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001688757-20-000015-index-headers.html	Edgar Link	pending
0001688757-20-000015-index.html	Edgar Link	pending
0001688757-20-000015.txt	Edgar Link	pending
0001688757-20-000015-xbrl.zip	Edgar Link	pending
businessa01.jpg	Edgar Link	pending
businessa05.jpg	Edgar Link	pending
businessa07.jpg	Edgar Link	pending
businessa08.jpg	Edgar Link	pending
businessa10.jpg	Edgar Link	pending
businessa11.jpg	Edgar Link	pending
businessa12.jpg	Edgar Link	pending
businessc03.jpg	Edgar Link	pending
chart-6a4b1de015835845b8e.jpg	Edgar Link	pending
esta-20191231.xml	Edgar Link	completed
esta-20191231.xsd	Edgar Link	pending
esta-20191231_cal.xml	Edgar Link	unprocessable
esta-20191231_def.xml	Edgar Link	unprocessable
esta-20191231_lab.xml	Edgar Link	unprocessable
esta-20191231_pre.xml	Edgar Link	unprocessable
establishmentlabs10k_2019q4.htm	Edgar Link	pending
exhibit211q42019.htm	Edgar Link	pending
exhibit311q42019.htm	Edgar Link	pending
exhibit312q42019.htm	Edgar Link	pending
exhibit321q42019.htm	Edgar Link	pending
exhibit48q42019.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
surfacefeatures.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2020 Q1 Form 10-K Financial Statement

#000168875720000015 Filed on March 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2020 Q1 Form 10-K Financial Statement

#000168875720000015 Filed on March 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta